{
    "id": "85899b95-661f-4027-9760-31a6fd175ff0",
    "indications": "diclofenac sodium/misoprostol indicated treatment signs symptoms osteoarthritis rheumatoid arthritis adult patients high risk developing nsaid-induced gastric duodenal ulcers complications . list factors may increase risk nsaid-induced gastric duodenal ulcers complications [ ( 5.3 ) ] .",
    "contraindications": "• lowest effective shortest duration consistent individual patient treatment goals . ( 2.1 ) • osteoarthritis : recommended maximal gi protection one tablet ( containing 50 mg diclofenac 200 mcg misoprostol ) three times daily . diclofenac higher 150 mg/day recommended . ( 2.2 ) • rheumatoid arthritis : recommended maximal gi protection one tablet ( containing 50 mg diclofenac 200 mcg misoprostol ) three four times daily diclofenac higher 200 mg/day recommended . ( 2.3 ) • modifications due intolerance , full prescribing information . ( 2.2 , 2.3 )",
    "warningsAndPrecautions": "diclofenac sodium misoprostol delayed-release tablets supplied : •50 mg diclofenac sodium 200 mcg misoprostol round , biconvex , white off-white tablets imprinted `` 50 `` middle one side `` g `` `` 0028 `` . •75 mg diclofenac sodium 200 mcg misoprostol round , biconvex , white off-white tablets imprinted `` 75 `` middle one side `` g `` `` 0029 `` . strengths supplied : strength ndc number size diclofenac sodium/misoprostol 50 50 mg diclofenac sodiumand200 mcg misoprostol 59762-0028-1 bottle 60 59762-0028-2 bottle 90 diclofenac sodium/misoprostol 75 75 mg diclofenac sodiumand200 mcg misoprostol 59762-0029-1 bottle 60",
    "adverseReactions": "diclofenac sodium/misoprostol contraindicated following patients : • pregnancy . misoprostol , component diclofenac sodium/misoprostol , pregnancy result maternal fetal harm , including uterine rupture , abortion , premature birth , birth defects [ ( 5.1 ) ( 8.1 ) ] •in setting coronary artery bypass graft ( cabg ) surgery [ ( 5.2 ) ] •active gastrointestinal bleeding [ ( 5.3 ) ] •history asthma , urticaria , allergic-type taking aspirin nsaids . severe , sometimes fatal , anaphylactic nsaids reported patients [ ( 5.8 , 5.9 ) ] •known hypersensitivity ( e.g . , anaphylactic serious skin ) diclofenac sodium misoprostol , prostaglandins , components product [ ( 5.8 , 5.10 ) ]",
    "ingredients": [
        {
            "name": "DICLOFENAC SODIUM",
            "code": "QTG126297Q"
        },
        {
            "name": "MISOPROSTOL",
            "code": "0E43V0BB57"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4"
        },
        {
            "name": "CROSPOVIDONE (120 .MU.M)",
            "code": "68401960MK"
        },
        {
            "name": "HYDROGENATED CASTOR OIL",
            "code": "ZF94AP8MEY"
        },
        {
            "name": "HYPROMELLOSE, UNSPECIFIED",
            "code": "3NXW29V3WO"
        },
        {
            "name": "LACTOSE, UNSPECIFIED FORM",
            "code": "J2B2A4N98G"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U"
        },
        {
            "name": "POVIDONE K30",
            "code": "U725QWY32X"
        },
        {
            "name": "SODIUM HYDROXIDE",
            "code": "55X04QC32I"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ"
        },
        {
            "name": "TALC",
            "code": "7SEV7J4R1U"
        },
        {
            "name": "TRIETHYL CITRATE",
            "code": "8Z96QXD6UM"
        }
    ],
    "organization": "Mylan Pharmaceuticals Inc.",
    "name": "Diclofenac sodium and Misoprostol",
    "effectiveTime": "20250522",
    "indications_original": "Diclofenac sodium/misoprostol is indicated for treatment of the signs and symptoms of osteoarthritis or rheumatoid arthritis in adult patients at high risk of developing NSAID-induced gastric and duodenal ulcers and their complications. For a list of factors that may increase the risk of NSAID-induced gastric and duodenal ulcers and their complications [see Warnings and Precautions (5.3)].",
    "contraindications_original": "• Use the lowest effective dosage for the shortest duration consistent with individual patient treatment goals. ( 2.1 ) • Osteoarthritis: The recommended dosage for maximal GI protection is one tablet (containing 50 mg of diclofenac and 200 mcg of misoprostol) three times daily. A dosage of diclofenac higher than 150 mg/day is not recommended. ( 2.2 ) • Rheumatoid Arthritis: The recommended dosage for maximal GI protection is one tablet (containing 50 mg of diclofenac and 200 mcg of misoprostol) three or four times daily A dosage of diclofenac higher than 200 mg/day is not recommended. ( 2.3 ) • For dosage modifications due to intolerance, see the full Prescribing Information. ( 2.2 , 2.3 )",
    "warningsAndPrecautions_original": "Diclofenac sodium and misoprostol delayed-release tablets are supplied as:\n                  \n                     \n                        •50 mg diclofenac sodium and 200 mcg misoprostol as round, biconvex, white to off-white tablets imprinted with a \"50\" in the middle on one side and \"G\" and \"0028\" on the other.\n                     \n                        •75 mg diclofenac sodium and 200 mcg misoprostol as round, biconvex, white to off-white tablets imprinted with a \"75\" in the middle on one side and \"G\" and \"0029\" on the other.\n                  \n                  The dosage strengths are supplied in:\n                  \n                     \n                     \n                     \n                     \n                     \n                        \n                           \n                              \n                                 Strength\n                              \n                           \n                           \n                              \n                                 NDC Number\n                              \n                           \n                           \n                              \n                                 Size\n                              \n                           \n                        \n                        \n                           \n                              Diclofenac sodium/misoprostol 50\n                           \n                           \n                              50 mg diclofenac sodiumand200 mcg misoprostol\n                           \n                           \n                              59762-0028-1\n                           \n                           \n                              bottle of 60\n                           \n                        \n                        \n                           \n                              59762-0028-2\n                           \n                           \n                              bottle of 90\n                           \n                        \n                        \n                           \n                              Diclofenac sodium/misoprostol 75\n                           \n                           \n                              75 mg diclofenac sodiumand200 mcg misoprostol\n                           \n                           \n                              59762-0029-1\n                           \n                           \n                              bottle of 60",
    "adverseReactions_original": "Diclofenac sodium/misoprostol is contraindicated in the following patients:\n                  \n                     \n                        •\n                        Pregnancy. Use of misoprostol, a component of diclofenac sodium/misoprostol, during pregnancy can result in maternal and fetal harm, including uterine rupture, abortion, premature birth, or birth defects [see Warnings and Precautions (5.1) and Use in Specific Populations (8.1)]\n                        \n                     \n                     \n                        •In the setting of coronary artery bypass graft (CABG) surgery [see Warnings and Precautions (5.2)]\n                     \n                     \n                        •Active gastrointestinal bleeding [see Warnings and Precautions (5.3)]\n                     \n                     \n                        •History of asthma, urticaria, or other allergic-type reactions after taking aspirin or other NSAIDs. Severe, sometimes fatal, anaphylactic reactions to NSAIDs have been reported in such patients [see Warnings and Precautions (5.8, 5.9)]\n                     \n                     \n                        •Known hypersensitivity (e.g., anaphylactic reactions and serious skin reactions) to diclofenac sodium and misoprostol, other prostaglandins, or any components of the drug product [see Warnings and Precautions (5.8, 5.10)]"
}